25 May 2013
Keywords: protherics, charms, profit, snake, venom, drug, uk-based
Article | 08 December 2003
UK-based biotechnology firm Protherics has reported a sharp narrowing oflosses for the fiscal first half ended September 30, after the company's
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
31 May 2004
24 May 2013
© 2013 thepharmaletter.com